These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 19231606
21. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer. Song T, Seong SJ, Lee SK, Kim BR, Ju W, Kim KH, Nam K, Sim JC, Kim TJ. J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702 [Abstract] [Full Text] [Related]
22. Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years. Jayasinghe Y, Rangiah C, Gorelik A, Ogilvie G, Wark JD, Hartley S, Garland SM. J Clin Virol; 2016 Mar; 76 Suppl 1():S74-S80. PubMed ID: 26589584 [Abstract] [Full Text] [Related]
23. [Methods of cervical cancer screening and facing new problems in China]. Zhang WH. Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):881-4. PubMed ID: 19173985 [No Abstract] [Full Text] [Related]
24. HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Wright TC. Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S239-46. PubMed ID: 17161163 [No Abstract] [Full Text] [Related]
27. The Annual Gynecologic Examination Updated for the 21st Century. Cappiello J, Levi A. Nurs Womens Health; 2016 Nov; 20(3):315-9. PubMed ID: 27287359 [Abstract] [Full Text] [Related]
28. Cervical Cancer Screening Revolution: Advancements with Confocal Endomicroscopy. Patil-Takbhate BR. Asian Pac J Cancer Prev; 2024 Mar 01; 25(3):723-724. PubMed ID: 38546053 [No Abstract] [Full Text] [Related]
29. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer. Gyllensten U, Sanner K, Gustavsson I, Lindell M, Wikström I, Wilander E. Br J Cancer; 2011 Aug 23; 105(5):694-7. PubMed ID: 21811250 [Abstract] [Full Text] [Related]
30. Pap test update. Heley S. Aust Fam Physician; 2007 Mar 23; 36(3):112-5. PubMed ID: 17339970 [Abstract] [Full Text] [Related]
32. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C. Eur J Gynaecol Oncol; 2004 Mar 23; 25(5):577-84. PubMed ID: 15493169 [Abstract] [Full Text] [Related]
33. Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia. Song T, Seong SJ, Lee SK, Kim BR, Ju W, Kim KH, Nam K, Sim JC, Kim TJ. Eur J Obstet Gynecol Reprod Biol; 2019 Mar 23; 234():112-116. PubMed ID: 30682600 [Abstract] [Full Text] [Related]
35. Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States. Hosier H, Sheth SS, Oliveira CR, Perley LE, Vash-Margita A. Am J Obstet Gynecol; 2021 Dec 23; 225(6):649.e1-649.e9. PubMed ID: 34256029 [Abstract] [Full Text] [Related]
37. Advances in cervical cancer screening and human papillomavirus vaccines. Feeley C. J Br Menopause Soc; 2006 Mar 23; 12(1):19-23. PubMed ID: 16513018 [Abstract] [Full Text] [Related]
40. Preventing cervical cancer in the Latina population. Flores K, Bencomo C. J Womens Health (Larchmt); 2009 Dec 23; 18(12):1935-43. PubMed ID: 20044855 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]